Skip to content

Efficacy and safety of the Qi-Gui-Yin formula on severe pneumonia: a multicenter, randomized, double-blinded, placebo-controlled clinical trial

Efficacy and safety of the Qi-Gui-Yin formula on severe pneumonia: a multicenter, randomized, double-blinded, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019785
Enrollment
Unknown
Registered
2018-11-28
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Control group:Qi-Gui-Yin placebo granules, 200 ml/time and 2 times/day
Experimental group:Qi-Gui-Yin formula granules, 200 ml/time, 2 times/day

Sponsors

Beijing institute of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria of severe pneumonia; (2) Aged 18 to 80 years; (3) patients or their families are aware of the study content and sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: (1) pregnancy or pregnancy preparation, or unable to take effective measures to prevent pregnancy; (2) persons with serious mental disorders; (3) the expected survival time of patients due to basic diseases is less than 28 days, such as poor control of malignant tumors and cardiac arrest within 30 days in the past; (4) plant survival state; (5) confirmed or highly suspected acute infectious diseases, such as viral hepatitis active stage, active stage tuberculosis, etc.; (6) allergy to the effective ingredients or auxiliary materials of the test drugs; (7) participated in clinical intervention trials in the past 3 months; (8) subjects who are considered unfit to participate in this study by the attending doctor.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
Mechanical ventilation time;Length of ICU stays;Antibiotic DDD value;Length of hospital stays;PSI Score;SOFA Score;CRP;PCT;Sputum specimen culture;

Countries

China

Contacts

Public ContactLiu Qingquan

Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University/Beijing institute of Traditional Chinese Medicine

liuqingquan_2003@126.com+86 010-52176677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026